CRA/Sr CRA - Early Development Services

PPD’s mission is to improve health. It starts as an idea to find a cure.

It becomes a life saved. All in-between, it’s you! We know that meaningful results not only require the right approach, but also the right people.

We invite you to re-imagine health promoting protocols with us, working alongside our talented, bright and energetic teams. Our global Early Development Services (EDS) is focused on Phase I trials which are designed to assess the safety (pharmacovigilance), tolerability, pharmacokinetics, and pharmacodynamics of an investigational drug or biologic.

Across a number of therapeutic areas, we specialize in the monitoring of these study designs: First in Human, Single Ascending Dose (SAD), Multiple Ascending Dose (MAD), Food Effect (FE), Drug-Drug Interaction (DDI), Bioavailability, Bioequivalence, ADME, Ethnic Bridging, Renal Impairment, and Hepatic Impairment. At PPD we hire the best, develop ourselves and each other, and recognize the power ...